Abstract
Despite the clear rationale for using hedgehog inhibitors in pancreatic cancer—they deplete the stroma to improve chemotherapy delivery—clinical results have been disappointing. New data suggest the large amounts of stroma surrounding some pancreatic cancers might actually have protective properties.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
